<i>TERT</i>promoter mutations contribute to<i>IDH</i>mutations in predicting differential responses to adjuvant therapies in WHO grade II and III diffuse gliomas
Ying Mao(Fudan University), Hai Yan(Wuhan University), Yu Yao(Qinghai University), Zhengping Zhuang(National Cancer Institute), Christopher S. Hong(Brigham and Women's Hospital), Ho‐Keung Ng(Chinese University of Hong Kong), Aden Ka‐Yin Chan, Yang Wang(Fudan University), Xin Zhang(Sichuan Cancer Hospital), Yin Wang(University of Michigan), Liangfu Zhou(Fudan University), Zhiyong Qin(Fudan University), Lingchao Chen(Allen Institute for Brain Science), Xiaojie Ding(Fudan University), Fangping Zhao
Cited by 36
Related Papers
Integrated Molecular Meta-Analysis of 1,000 Pediatric High-Grade and Diffuse Intrinsic Pontine Glioma
|Cancer Cell|2017|1.3k
Intertumoral Heterogeneity within Medulloblastoma Subgroups
|Cancer Cell|2017|1.3k
CGCG clinical practice guidelines for the management of adult diffuse gliomas
|Cancer Letters|2016|650
Ferroptosis, a novel pharmacological mechanism of anti-cancer drugs
|Cancer Letters|2020|586
Clinical practice guidelines for the management of adult diffuse gliomas
|Cancer Letters|2020|482